Viewing StudyNCT00030875



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00030875
Status: COMPLETED
Last Update Posted: 2023-08-04
First Post: 2002-02-14

Brief Title: Bortezomib in Treating Patients With Mantle Cell Lymphoma
Sponsor: NCIC Clinical Trials Group
Organization: Canadian Cancer Trials Group

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Keywords:
Name View
stage I mantle cell lymphoma View
contiguous stage II mantle cell lymphoma View
noncontiguous stage II mantle cell lymphoma View
stage III mantle cell lymphoma View
stage IV mantle cell lymphoma View
recurrent mantle cell lymphoma View